BRAINSTORM CELL THERAPEUTICS INC. Short-term Investments
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) had Short-term Investments of $196.00 thousand as of 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:ShortTermInvestments · last filed 2024-04-01
- 2023-09-30: Short-term Investments $196.00K.
- 2023-06-30: Short-term Investments $202.00K.
- 2023-03-31: Short-term Investments $206.00K.
- 2022-12-31: Short-term Investments $2.21M.
| Period end | Short-term Investments |
|---|---|
| 2023-09-30 | $196.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $202.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $206.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $2.21M 10-K · filed 2024-04-01 |
| 2022-09-30 | $3.25M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $3.24M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $3.25M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $3.24M 10-K · filed 2023-03-30 |
| 2021-09-30 | $2.11M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $4.05M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $4.11M 10-Q · filed 2021-04-26 |
| 2020-12-31 | $4.11M 10-K · filed 2022-03-28 |
| 2020-09-30 | $4.04M 10-Q · filed 2020-10-15 |
| 2020-06-30 | $4.04M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $2.02M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $33.00K 10-K · filed 2021-02-04 |
| 2019-09-30 | $34.00K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $1.57M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $2.99M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $6.12M 10-K · filed 2020-02-18 |
| 2018-09-30 | $10.19M 10-Q · filed 2018-10-29 |
| 2018-06-30 | $15.18M 10-Q · filed 2018-07-23 |
| 2018-03-31 | $2.36M 10-Q · filed 2018-05-14 |
| 2017-12-31 | $5.27M 10-K · filed 2019-04-01 |
| 2017-09-30 | $8.08M 10-Q · filed 2017-10-17 |
| 2017-06-30 | $933.00K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $7.74M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $9.44M 10-K · filed 2018-03-08 |
| 2016-09-30 | $10.24M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $10.54M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $10.73M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $15.53M 10-K · filed 2017-03-29 |
| 2015-09-30 | $16.44M 10-Q · filed 2015-11-16 |
| 2015-06-30 | $18.39M 10-Q · filed 2015-08-13 |
| 2015-03-31 | $17.86M 10-Q · filed 2015-05-14 |
| 2014-12-31 | $4.29M 10-K · filed 2016-03-09 |
| 2014-09-30 | $1.60M 10-Q · filed 2014-11-13 |
| 2013-12-31 | $0.00 10-K · filed 2015-03-26 |
| 2013-09-30 | $4.79M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $1.78M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $1.77M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $2.77M 10-K · filed 2014-03-27 |
| 2011-12-31 | $0.00 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |